Log in
Enquire now
‌

US Patent 9814714 Kinase modulation, and indications therefor

Patent 9814714 was granted and assigned to Plexxikon Inc. on November, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Date Filed
May 20, 2016
0
Date of Patent
November 14, 2017
0
Patent Applicant
Plexxikon Inc.
Plexxikon Inc.
0
Patent Application Number
15160729
0
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Inventor Names
Guoxian Wu
0
Todd Ewing
0
Wayne Spevak
0
Ying Zhang
0
Chao Zhang
0
Gideon Bollag
0
Hanna Cho
0
Jack Lin
0
Jiazhong Zhang
0
Marika Nespi
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9814714
0
Patent Primary Examiner
‌
Raymond Henley, III
0

Find more entities like US Patent 9814714 Kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.